Advanced age,
obesity, and
muscle weakness are independent factors in the onset of
deep vein thrombosis (DVT). Recently, an association between
sarcopenia and DVT has been reported. We hypothesized that
sarcopenia related factors, observed by ultrasonography, are associated with the regression effect on the
thrombus following anticoagulation
therapy. The present study focused on gastrocnemius muscle (GCM) thickness and the GCM's internal echogenic brightness. We examined the association with DVT regression following direct oral
anticoagulants (DOACs) treatment.The prospective cohort study period was between October 2017 and August 2018. We enrolled 46 patients diagnosed with DVT by ultrasonography, who were aged >60 years old and treated with DOACs.
Sarcopenia was evaluated using the Asian Working Group for
Sarcopenia flowchart. The average DOACs treatment period was 94 days, and 29 patients exhibited
thrombus regression. On univariate logistic regression analysis,
sarcopenia, average GCM diameter index, and gastrocnemius integrated backscatter index were significantly associated with
thrombus regression. In a multivariate model, only the average GCM diameter index correlated with
thrombus regression.The average GCM diameter index is associated with DVT regression treated with DOACs. Considering the GCM diameter during DVT treatment can be a marker to make a decision for the treatment of DVT.